These findings suggest that the increase in ABCB1 induced by chemotherapy rather than the background ABCB1 expression is response for chemo-resistance and impaired survival and ABCB1 may play an essential role in the development of acquired drug resistance in ovarian cancer. Here, ABCB1 is linked to ovarian carcinoma.